BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: So J, Lewis AC, Smith LK, Stanley K, Franich R, Yoannidis D, Pijpers L, Dominguez P, Hogg SJ, Vervoort SJ, Brown FC, Johnstone RW, McDonald G, Ulanet DB, Murtie J, Gruber E, Kats LM. Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia. EMBO Mol Med 2022;:e15203. [PMID: 35514210 DOI: 10.15252/emmm.202115203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 2023;108:353-66. [PMID: 36722405 DOI: 10.3324/haematol.2022.280800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mullen NJ, Thakur R, Shukla SK, Chaika NV, Kollala SS, Wang D, He C, Fujii Y, Sharma S, Mulder SE, Sykes DB, Singh PK. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. Cancer Letters 2023;552:215981. [DOI: 10.1016/j.canlet.2022.215981] [Reference Citation Analysis]
3 Donato E, Trumpp A. Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis. EMBO Mol Med 2022;:e16171. [PMID: 35694783 DOI: 10.15252/emmm.202216171] [Reference Citation Analysis]